Sarda Proteins Share Price ₹130 | P/E 36.4

Quarterly Results, Profit & Loss, Balance Sheet, Cash Flows, and Ratios are shown below as separate sections.

Financials of Sarda Proteins

Quarter-by-quarter operating performance

	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026
Sales +	0.74	0.24	0.00	1.00	0.06	0.00	0.14	24.05	0.00	10.95	4.30	0.25	0.65
Expenses +	0.77	0.28	0.05	1.03	0.08	0.08	0.03	23.95	0.10	11.44	4.01	0.37	0.05
Operating Profit	-0.03	-0.04	-0.05	-0.03	-0.02	-0.08	0.11	0.10	-0.10	-0.49	0.29	-0.12	0.60
OPM %	-4.05%	-16.67%		-3.00%	-33.33%		78.57%	0.42%		-4.47%	6.74%	-48.00%	92.31%
Other Income +	0.04	0.04	0.04	0.04	0.04	0.00	0.00	0.00	0.00	0.00	0.11	0.00	0.24
Interest	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Depreciation	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Profit before tax	0.01	0.00	-0.01	0.01	0.02	-0.08	0.11	0.10	-0.10	-0.49	0.40	-0.12	0.84
Tax %	500.00%		0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	20.00%	0.00%	0.00%	0.00%	0.00%
Net Profit +	-0.04	0.00	-0.01	0.01	0.02	-0.08	0.11	0.10	-0.11	-0.49	0.40	-0.12	0.84
EPS in Rs	-0.23	0.00	-0.06	0.06	0.12	-0.46	0.64	0.58	-0.64	-2.84	2.32	-0.70	0.94

Financials of Sarda Proteins

Annual income statement trend

	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Sales +	5.02	2.06	6.18	5.65	7.22	5.40	11.36	10.76	5.80	1.30	24.19	16.16
Expenses +	5.14	2.18	6.35	6.00	7.33	5.31	11.38	10.50	5.95	1.45	24.17	15.87
Operating Profit	-0.12	-0.12	-0.17	-0.35	-0.11	0.09	-0.02	0.26	-0.15	-0.15	0.02	0.29
OPM %	-2.39%	-5.83%	-2.75%	-6.19%	-1.52%	1.67%	-0.18%	2.42%	-2.59%	-11.54%	0.08%	1.79%
Other Income +	0.80	0.00	0.00	-0.01	0.03	0.08	0.08	0.09	0.16	0.17	0.00	0.35
Interest	0.02	0.03	0.01	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Depreciation	0.04	0.02	0.01	0.01	0.01	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Profit before tax	0.62	-0.17	-0.19	-0.37	-0.09	0.17	0.06	0.35	0.01	0.02	0.02	0.64
Tax %	4.84%	-5.88%	-31.58%	-10.81%	44.44%	82.35%	133.33%	14.29%	500.00%	0.00%	100.00%	0.00%
Net Profit +	0.59	-0.15	-0.13	-0.33	-0.12	0.03	-0.02	0.31	-0.03	0.02	0.01	0.64
EPS in Rs	1.80	-0.87	-0.75	-1.91	-0.70	0.17	-0.12	1.80	-0.17	0.12	0.06	0.71
Dividend Payout %	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%

Financials of Sarda Proteins

Capital structure and asset base

	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Equity Capital	2.43	2.50	2.50	2.50	2.50	2.50	2.50	2.50	2.50	2.50	2.50	2.50
Reserves	0.30	0.15	0.02	-0.31	-0.44	-0.41	-0.43	-0.12	-0.15	-0.13	-0.13	0.51
Borrowings +	0.21	0.61	0.20	0.00	0.01	0.00	0.00	0.00	0.00	0.00	0.00	0.16
Other Liabilities +	0.20	0.21	0.20	0.13	0.12	0.06	0.07	0.07	0.05	0.07	0.28	83.44
Total Liabilities	3.14	3.47	2.92	2.32	2.19	2.15	2.14	2.45	2.40	2.44	2.65	86.61
Fixed Assets +	0.10	0.06	0.05	0.03	0.02	0.01	0.01	0.00	0.00	0.00	0.00	0.00
CWIP	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Investments	0.01	0.01	0.01	0.01	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Other Assets +	3.03	3.40	2.86	2.28	2.17	2.14	2.13	2.45	2.40	2.44	2.65	86.61
Total Assets	3.14	3.47	2.92	2.32	2.19	2.15	2.14	2.45	2.40	2.44	2.65	86.61

Financials of Sarda Proteins

Operating, investing and financing cash movement

	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Cash from Operating Activity +	-0.72	-1.20	-0.09	0.48	-0.59	-0.05	-0.05	0.10	-0.30	-0.23	-0.11	-76.39
Cash from Investing Activity +	1.90	0.20	0.00	0.02	0.11	0.09	0.08	0.09	0.16	0.17	0.00	0.36
Cash from Financing Activity +	-0.13	0.37	-0.42	-0.20	0.01	-0.01	0.00	0.00	0.00	0.00	0.03	83.51
Net Cash Flow	1.05	-0.63	-0.51	0.30	-0.47	0.03	0.03	0.19	-0.14	-0.07	-0.08	7.48
Free Cash Flow	0.73	-1.18	-0.09	0.48	-0.59	-0.04	-0.05	0.10	-0.30	-0.23	-0.11	-76.38
CFO/OP	525%	1,000%	53%	-134%	536%	-22%	200%	38%	200%	153%	-550%	-26,341%

Financials of Sarda Proteins

Working capital efficiency and return ratios

	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Debtor Days	13.81	0.00	38.98	44.58	36.40	56.10	24.74	7.12	0.00	0.00	0.00	96.44
Inventory Days	32.70	324.22	64.41	28.64	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Days Payable	0.76	0.00	0.61	0.00
Cash Conversion Cycle	45.75	324.22	102.78	73.22	36.40	56.10	24.74	7.12	0.00	0.00	0.00	96.44
Working Capital Days	65.44	251.60	108.08	76.23	83.92	114.91	55.91	64.45	130.27	603.65	33.95	-104.35
ROCE %	-5.93%	-4.52%	-6.02%	-14.66%	-5.63%	8.17%	2.88%	15.73%	0.42%	0.85%	0.84%	23.06%

Dwarikesh Sugar Industries Ltd (Q4 FY23)
If you can provide a valid transcript or document, I will be happy to assist with your query. Key concall takeaways from Dwarikesh Sugar Industries Ltd's Q4…
Dwarikesh Sugar Industries Ltd (Q3 FY23)
The provided PDF page contains a "500 . Key concall takeaways from Dwarikesh Sugar Industries Ltd's Q3 FY23 earnings call — and how it ranks against sector…
Chamanlal Setia Exports Ltd (Q1 FY27)
Management is optimistic about sustaining EBITDA margins (12-14%) with profitable business mix. Key concall takeaways from Chamanlal Setia's Q1 FY27 earnings…
Kaveri Seed Company Ltd (Q1 FY27)
100 crores revenue in vegetables within 3 to 5 years. Key concall takeaways from Kaveri Seed Company Ltd's Q1 FY27 earnings call — and how it ranks against…

Sarda Proteins Share Price & Earnings Call Analysis